Subscribe to:
POZ magazine E-newsletters
POZ Personals Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
H1N1 (Swine Flu) and You
Life Expectancy With HIV Increases Dramatically
HIV Associated With Marked Declines in Lung Function
Is Marijuana as Effective as OTC and Prescription Drugs?
HPV Vaccine Is Active in MSM
MACS Turns 25: The Influential HIV Study Continues
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from CancerWEB's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

May 13, 2008

High Cholesterol Good for Hepatitis C Treatment?

Having higher levels of “bad” low-density lipoprotein (LDL) cholesterol is associated with a better response to hepatitis C (HCV) treatment in people infected with both HIV and HCV, say the authors of a study published in the May 11 issue of AIDS. This raises the question of whether a problematic side effect of many antiretroviral (ARV) drugs—increases in LDL—may actually be advantageous for people living with HIV undergoing treatment for HCV.

In people infected with HCV, but not HIV, studies have found that having a higher total cholesterol level and higher levels of LDL cholesterol is associated with having a sustained virologic response (SVR) to HCV treatment. An SVR is defined as an undetectable HCV viral load six months after completing HCV treatment. José del Valle, MD, from the Hospital Universitario de Valme in Sevilla, Spain, and his colleagues set out to determine whether the same thing would be true in people coinfected with HIV and HCV. From a cohort of 3,564 coinfected patients, del Valle’s team analyzed data from 339 who had received HCV treatment.

In all, 39 percent of the patients who were treated achieved an SVR. People with a higher LDL cholesterol level (above 100 mg/dL) were more likely to have an SVR. This result was statistically significant, meaning that the difference was too great to have occurred by chance. Total cholesterol, however, did not influence whether people had an SVR. Given the beneficial impact of higher LDL on HCV treatment, del Valle’s team concludes that further analysis of the use of various ARV drugs most likely to elevate LDL levels should be conducted.

Search: low-density lipoprotein, LDL, cholesterol, hepatitis C, HCV, Jose del Valle


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 1 (of 1 total)    

Samuel, Washington DC, 2008-05-14 10:42:40
Well for someone that is going to undergo treatment for Hep C soon it is a slight ray of sun considering the treatment is not fun. I just learned that my cholestrol has gone up after being so good for years. We need all the help that we can get.

comments 1 - 1 (of 1 total)    


[Go to top]

Get Started
Get Answers
I'm HIV positive. What's next?
How to find a support system
Things you should know before starting treatment
How to handle side effects and other concerns
How to tell someone you have HIV/AIDS
Conference Coverage

CROI 2009
Montréal, Canada
February 8-11, 2009


48th Annual ICAAC/IDSA 46th Annual Meeting
Washington, DC
October 25-28, 2008


XVII International AIDS Conference
Mexico City, Mexico
August 3-8, 2008


more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]